There's been plenty of volatility in the tech market this week off the back of the recent DeepSeek fiasco. Despite things ...

We recently compiled a list of the 10 Important AI News and Ratings for Today. In this article, we are going to take a look ...

We recently compiled a list of the 10 Important AI News and Ratings for Today. In this article, we are going to take a look ...

DeepSeek spooked US markets on news that the model’s developers were able to produce a worthy competitor to American AI firms ...

The line between dividend stocks and non-dividend tech stocks is now blurrier than ever, as 71% of the Magnificent 7 now pay ...

We recently published a list of 10 Unstoppable Tech Stocks to Buy Right Now. In this article, we are going to take a look at ...

Apple stock has held up this week, while Nvidia has fallen. The iPhone maker is heading into earnings holding the title of most valuable company. This has been an incredibly busy week for the stock ...

Key tech stocks were a mixed bag in early trading Thursday after executives at Meta and Microsoft said they plan to keep ...

Apple’s report Thursday afternoon is the latest in a busy week for earnings and will provide a test for the iPhone maker’s ...

Energy demands from big tech, including for AI, has elected officials giving an old power source a second look. Story from @CalMatters.org.

It recently reported its fiscal Q2 2025 earnings. The stock tanked by 4% but started recovering immediately and is now down by 2% after earnings. Let’s take a look into what happened.

AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...